Neuroprotective effects of lithium in cultured cells and animal models of diseases
- 1 April 2002
- journal article
- review article
- Published by Wiley in Bipolar Disorders
- Vol. 4 (2) , 129-136
Abstract
Lithium, the major drug used to treat manic depressive illness, robustly protects cultured rat brain neurons from glutamate excitotoxicity mediated by N‐methyl‐D‐aspartate (NMDA) receptors. The lithium neuroprotection against glutamate excitotoxiciy is long‐lasting, requires long‐term pretreatment and occurs at therapeutic concentrations of this drug. The neuroprotective mechanisms involve inactivation of NMDA receptors, decreased expression of pro‐apoptotic proteins, p53 and Bax, enhanced expression of the cytoprotective protein, Bcl‐2, and activation of the cell survival kinase, Akt. In addition, lithium pretreatment suppresses glutamate‐induced loss of the activities of Akt, cyclic AMP‐response element binding protein (CREB), c‐Jun – N‐terminal kinase (JNK) and p38 kinase. Lithium also reduces brain damage in animal models of neurodegenerative diseases in which excitotoxicity has been implicated. In the rat model of stroke using middle cerebral artery occlusion, lithium markedly reduces neurologic deficits and decreases brain infarct volume even when administered after the onset of ischemia. In a rat Huntington's disease model, lithium significantly reduces brain lesions resulting from intrastriatal infusion of quinolinic acid, an excitotoxin. Our results suggest that lithium might have utility in the treatment of neurodegenerative disorders in addition to its common use for the treatment of bipolar depressive patients.Keywords
This publication has 56 references indexed in Scilit:
- The multifaceted roles of glycogen synthase kinase 3β in cellular signalingProgress in Neurobiology, 2001
- Lithium protects cultured neurons against β‐amyloid‐induced neurodegenerationFEBS Letters, 1999
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- Apoptosis Induction by Caspase-8 Is Amplified through the Mitochondrial Release of Cytochrome cJournal of Biological Chemistry, 1998
- AP-1 function and regulationCurrent Opinion in Cell Biology, 1997
- Subgenual prefrontal cortex abnormalities in mood disordersNature, 1997
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.Journal of Experimental Medicine, 1996
- Lithium Delays the Radiation-induced Apoptotic Process in External Granule Cells of Mouse Cerebellum.Journal of Radiation Research, 1995
- Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.Genes & Development, 1993